Young-Sook Song
Chief Executive Officer chez HANMI SCIENCE CO., LTD.
Fortune : 250 M $ au 31/03/2024
Profil
Young-Sook Song occupe le poste de présidente et co-directrice générale de Hanmi Science Co., Ltd. Elle a obtenu un diplôme de premier cycle à l'université des femmes de Sookmyung.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HANMI SCIENCE CO., LTD
12,56% | 01/04/2024 | 8 789 671 ( 12,56% ) | 250 M $ | 31/03/2024 |
Postes actifs de Young-Sook Song
| Sociétés | Poste | Début |
|---|---|---|
| HANMI SCIENCE CO., LTD. | Chief Executive Officer | - |
Beijing Hanmi Pharmaceutical Co., Ltd.
 Beijing Hanmi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Hanmi Pharmaceutical Co., Ltd., Beijing Hanmi Pharmaceutical Co., Ltd. is a pharmaceutical company based in Beijing, CN. Beijing Hanmi Pharmaceutical Co. specializes in respiratory, pediatric, digestive, orthopedic, and anti-infective drugs, among others. The Chinese company also has research centers and development alliances. The private company has a range of products, including probiotics for infants and young children, and medicine for respiratory diseases, cough, fever, and pain relief. The company is committed to social responsibility and has participated in various public welfare projects. The company was founded in 1996, and the CEO is Hai Long Ren. | Chairman | - |
Formation de Young-Sook Song
| Sookmyung Women's University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Beijing Hanmi Pharmaceutical Co., Ltd.
Beijing Hanmi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Hanmi Pharmaceutical Co., Ltd., Beijing Hanmi Pharmaceutical Co., Ltd. is a pharmaceutical company based in Beijing, CN. Beijing Hanmi Pharmaceutical Co. specializes in respiratory, pediatric, digestive, orthopedic, and anti-infective drugs, among others. The Chinese company also has research centers and development alliances. The private company has a range of products, including probiotics for infants and young children, and medicine for respiratory diseases, cough, fever, and pain relief. The company is committed to social responsibility and has participated in various public welfare projects. The company was founded in 1996, and the CEO is Hai Long Ren. | Health Technology |
| Hanmi Science Co., Ltd. |
